1.Cerebral Air Embolism Following a Gastroscopy.
Dong Beom SONG ; Hyun Ji CHO ; Byoung Seok YE ; Ji Hoe HEO
Journal of the Korean Neurological Association 2008;26(2):146-148
Cerebral air embolism, the entry of air into the cerebral artery, is an iatrogenic clinical problem in most cases, which may result in seizure, severe neurologic deficits and even death. Although cerebral air embolism may result from almost all procedures that are performed in clinical specialties, occurrence following a gastroscopy is very rare. We report a patient who developed cerebral air embolism following a gastroscopy.
Cerebral Arteries
;
Embolism, Air
;
Gastroscopy
;
Humans
;
Neurologic Manifestations
;
Seizures
2.A Case of Idiopathic Intracranial Hypertension Treated with Optic Nerve Sheath Fenestration.
Sung Ryoung LIM ; Hyeong Jun KIM ; Jong Su YE ; Ji Hun JANG ; Kyoung HEO ; Hyo Kun CHO
Journal of the Korean Neurological Association 1994;12(4):770-775
Idiopathic intracranial hypertension, a syndrome of obscure origin, occurs particularly in fat adolescent girls and young women. The usual symptoms are headache, blurred vision, a vague dizziness, horizontal diplopia and transient visual obscurations etc., and ophthalmoscopic examination reveals papillederma, due to increased ICP. Visual field testing usually shows slight peripheral constrictions with enlargement of the blind sports. CSF pressure is elevated in the range of 250 to 450 mm of water. Radiological or the other laboratory tests show no specific abnormalities. Treatment for idiopathic intracranial hypertension is focused on early detection and prevention of vision loss, the only permanent morbidity. Many different modes of medical treatment, including weight reduction, repeated lumber puncture, corticosteroids, diuretics, glycerol or carbonic anhydrase inhibitors, have successfully been tried up to 90% of the patients. In the remaining patients, particularly in those with measurable impairment of vision that does not respond to conventinal medical therapies, surgical procedure should be considered. We report a case of idiopathic intracranial hypertension successfully treated with optic nerve sheath fenestration.
Adolescent
;
Adrenal Cortex Hormones
;
Carbonic Anhydrase Inhibitors
;
Constriction
;
Diplopia
;
Diuretics
;
Dizziness
;
Female
;
Glycerol
;
Headache
;
Humans
;
Optic Nerve*
;
Pseudotumor Cerebri*
;
Punctures
;
Sports
;
Visual Field Tests
;
Water
;
Weight Loss
3.Full-mouth rehabilitation by immediate implantation combined with orthognathic surgery: a clinical report.
Hye Rim AHN ; Ji Ye HEO ; Chul Hoon KIM ; Hee Seong HWANG ; Bok Joo KIM
The Journal of Korean Academy of Prosthodontics 2016;54(1):57-64
Clinical therapy that combines full-mouth rehabilitation with immediate implantation and orthognathic surgery poses a challenge to prosthodontists. This clinical report describes a multidisciplinary approach to the diagnosis and treatment of a patient presenting with skeletal discrepancy and rampant caries. The results thus achieved indicate that full-mouth rehabilitation by fixed immediate and early loading implantation accompanied by orthognathic surgery can be a predictable and effective treatment procedure.
Diagnosis
;
Humans
;
Orthognathic Surgery*
;
Rehabilitation*
5.Apoptotic Effect of Co-Treatment with a Natural Product, Chios Gum Mastic, and a Proteasome Inhibitor, Lactacystin, on Human Osteosarcoma Cells.
Chul Jung BAEK ; Ji Ye HEO ; Gyoo Cheon KIM ; Hyun Ho KWAK ; In Ryoung KIM ; Seung Eun LEE ; Chul Hoon KIM ; Na Young JEONG ; Bong Soo PARK
Korean Journal of Anatomy 2008;41(2):129-138
Chios gum mastic (CGM) is a resinous exudate obtained from the stem and the main leaves of Pistacia lenticulus tree native to Mediterranean areas. Recently, it was reported that CGM induced apoptosis in a few cancer cells in vitro. Since recent studies indicated the synergistic interactions between the apoptotic stimulus and a proteasome inhibitor, the ubiquintin-proteasome pathway has become an attractive target in cancer therapy. And to date, there has been no report of the synergistic apoptotic effect between CGM and a proteasome inhibitor to become an attractive target in cancer therapy. Therefore, this study was undertaken to investigate the synergistic apoptotic effect of co-treatment with a natural product, CGM, and a proteasome inhibitor, lactacystin, on human osteosarcoma (HOS) cells. To investigate whether the co-treatment of CGM and lactacystin compared with each single treatment efficiently induced apoptosis on HOS cells, MTT assay, DNA electrophoresis, Hoechst staining, DNA hypoploidy assay, Westen blot analysis, immunofluorescent staining, proteasome activity and mitochondrial membrane potential (MMP) change were performed. In this study, HOS cells co-treated with CGM and lactacystin showed several lines of apoptotic manifestation such as nuclear condensation, DNA fragmentation, the reduction of MMP and proteasome activity, the decrease of DNA content, the release of cytochrome c into cytosol, the translocation of AIF and DFF40 (CAD) onto nuclei, and activation of caspase-7, caspase-3, PARP and DFF45 (ICAD) whereas each single treated HOS cells hardly showed. We presented data indicating that the co-treatment of CGM and lactacystin induced potentially apoptosis whereas each single treatment did slightly. Moreover, the co-treatment of CGM and lactacystin potentiated the inhibition of proteasome activity. Therefore, our data provide the possibility that combination therapy of CGM and lactacystin could be considered as a novel therapeutic strategy for human osteosarcoma.
Acetylcysteine
;
Apoptosis
;
Caspase 3
;
Caspase 7
;
Cytochromes c
;
Cytosol
;
DNA
;
DNA Fragmentation
;
Electrophoresis
;
Exudates and Transudates
;
Gingiva
;
Humans
;
Membrane Potential, Mitochondrial
;
Osteosarcoma
;
Pistacia
;
Proteasome Endopeptidase Complex
;
Proteasome Inhibitors
;
Resins, Plant
;
Trees
6.Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia.
Mi Suk LEE ; Jee Youn OH ; Cheol In KANG ; Eu Suk KIM ; Sunghoon PARK ; Chin Kook RHEE ; Ji Ye JUNG ; Kyung Wook JO ; Eun Young HEO ; Dong Ah PARK ; Gee Young SUH ; Sungmin KIEM
Infection and Chemotherapy 2018;50(2):160-198
Community-acquired pneumonia is common and important infectious disease in adults. This work represents an update to 2009 treatment guideline for community-acquired pneumonia in Korea. The present clinical practice guideline provides revised recommendations on the appropriate diagnosis, treatment, and prevention of community-acquired pneumonia in adults aged 19 years or older, taking into account the current situation regarding community-acquired pneumonia in Korea. This guideline may help reduce the difference in the level of treatment between medical institutions and medical staff, and enable efficient treatment. It may also reduce antibiotic resistance by preventing antibiotic misuse against acute lower respiratory tract infection in Korea.
Adult*
;
Communicable Diseases
;
Community-Acquired Infections
;
Diagnosis
;
Drug Resistance, Microbial
;
Humans
;
Korea
;
Medical Staff
;
Pneumonia*
;
Respiratory Tract Infections
7.Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia.
Mi Suk LEE ; Jee Youn OH ; Cheol In KANG ; Eu Suk KIM ; Sunghoon PARK ; Chin Kook RHEE ; Ji Ye JUNG ; Kyung Wook JO ; Eun Young HEO ; Dong Ah PARK ; Gee Young SUH ; Sungmin KIEM
Infection and Chemotherapy 2018;50(2):160-198
Community-acquired pneumonia is common and important infectious disease in adults. This work represents an update to 2009 treatment guideline for community-acquired pneumonia in Korea. The present clinical practice guideline provides revised recommendations on the appropriate diagnosis, treatment, and prevention of community-acquired pneumonia in adults aged 19 years or older, taking into account the current situation regarding community-acquired pneumonia in Korea. This guideline may help reduce the difference in the level of treatment between medical institutions and medical staff, and enable efficient treatment. It may also reduce antibiotic resistance by preventing antibiotic misuse against acute lower respiratory tract infection in Korea.
Adult*
;
Communicable Diseases
;
Community-Acquired Infections
;
Diagnosis
;
Drug Resistance, Microbial
;
Humans
;
Korea
;
Medical Staff
;
Pneumonia*
;
Respiratory Tract Infections
8.Factors associated with the Discrepancy between Exercise Capacity and Airflow Limitation in Patients with Chronic Obstructive Pulmonary Disease
Tae Hoon KIM ; I Re HEO ; Na Young KIM ; Joo Hun PARK ; Hee-Young YOON ; Ji Ye JUNG ; Seung Won RA ; Ki-Suck JUNG ; Kwang Ha YOO ; Ho Cheol KIM
Tuberculosis and Respiratory Diseases 2024;87(2):155-164
Background:
Exercise capacity is associated with lung function decline in chronicobstructive pulmonary disease (COPD) patients, but a discrepancy between exercisecapacity and airflow limitation exists. This study aimed to explore factors contributingto this discrepancy in COPD patients.
Methods:
Data for this prospective study were obtained from the Korean COPD SubgroupStudy. The exercise capacity and airflow limitation were assessed using the6-minute walk distance (6-MWD; m) and forced expiratory volume in 1 second (FEV1).Participants were divided into four groups: FEV1 >50%+6-MWD >350, FEV1 >50%+6-MWD ≤350, FEV1 ≤50%+6-MWD >350, and FEV1 ≤50%+6-MWD ≤350 and their clinicalcharacteristics were compared.
Results:
A total of 883 patients (male:female, 822:61; mean age, 68.3±7.97 years) wereenrolled. Among 591 patients with FEV1 >50%, 242 were in the 6-MWD ≤350 group, andamong 292 patients with FEV1 ≤50%, 185 were in the 6-MWD >350 group. The multipleregression analyses revealed that male sex (odds ratio [OR], 8.779; 95% confidence interval[CI], 1.539 to 50.087; p=0.014), current smoking status (OR, 0.355; 95% CI, 0.178to 0.709; p=0.003), and hemoglobin levels (OR, 1.332; 95% CI, 1.077 to 1.648; p=0.008)were significantly associated with discrepancies in exercise capacity and airflow limitationin patients with FEV1 >50%. Meanwhile, in patients with FEV1 ≤50%, diffusioncapacity of carbon monoxide (OR, 0.945; 95% CI, 0.912 to 0.979; p=0.002) was significantlyassociated with discrepancies between exercise capacity and airflow limitation.
Conclusion
The exercise capacity of COPD patients may be influenced by factors otherthan airflow limitation, so these aspects should be considered when assessing andtreating patients.